Technology
Oracle Corporation ORCL
$119.09
-6.26 (-4.99%) today
ORCL
Oracle Corporation—
Today
— · USD
Loading prices…
Revenue by Product & Services
Loading…
Revenue Breakdown
—
Past 5 years
Loading prices…
Profit & Cash Flow
Show
RevenueOperating IncomeFree Cash FlowExpenses
Each bar stacks the items you turn on; hover a bar for each amount. Expenses = revenue minus operating income. Figures from SEC filings.
Tip: click any year on a chart to see all of its numbers.
Market Cap
$347.0B+2198%
Revenue
$67.4B+71%
Break down by
Loading revenue breakdown…
Operating Income
$20.6B+55%
Net Income
$17.0B+373%
Free Cash Flow
$-23.7B-274%
Revenue to Market Cap
0.16x-94%
P/E Ratio
24.90x+493%
Operating Margin
30.6%-9%
Debt to Equity
—
Not reported for this period
Shares Outstanding
2.91B+878%
Dividend Yield
1.4%-8%
Latest ORCL news
- Michael Burry Buys More Of Adobe And MercadoLibre; Exits ORCL, CAT Puts11/16/2026
- Here's Why Oracle (ORCL) Fell More Than Broader Market11/16/2026
- CoreWeave, Oracle and Nebius Plunge as Nvidia Fallout Rattles AI Stocks11/16/2026
- Is Oracle (ORCL) Undervalued Following Its Expanded Federal Health Data Exchange Deal?11/16/2026
- E-Clinical Trial Technologies - Global Strategic Business Report 2026: Capitalize on 16.6% CAGR to US$32.8 Billion by 2032 as Oracle, Medidata, BioClinica and PAREXEL Disrupt Digital Trials11/16/2026
- Clinical Trial Management Systems (CTMS) - Global Strategic Business Report 2026: Capitalize on 17.5% CAGR to $7 Billion by 2032; Benchmark Oracle, Veeva Systems, Medidata Solutions and ArisGlobal11/16/2026
Prices and news from Yahoo Finance (may be delayed). Company results from SEC filings (available from 2007). Not investment advice.